SCHEMBL16151925

SCHEMBL16151925

COCCNC[C@@H](C(C)=O)c1ccc(C)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 5/20 0.38
HPGD P15428 3/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 1/20 0.38
NPC1 O15118 1/20 0.38
ALOX12 P18054 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.37
AKT1 P31749 1/20 0.37
AKT2 P31751 1/20 0.37
AKT3 Q9Y243 1/20 0.37
POLB P06746 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL684413 0.87 AKT1 (0.46) L3MBTL1ALDH1A1HPGDHTTMAPT
SCHEMBL16151958 0.82 ESR1 (0.38) L3MBTL1ATMTDP1ALDH1A1HPGD
SCHEMBL16151932 0.78 L3MBTL1 (0.43) L3MBTL1TDP1ALDH1A1HPGDLMNA
SCHEMBL16151907 0.76 LMNA (0.40) L3MBTL1ALDH1A1LMNASMN1; SMN2POLB
SCHEMBL16151886 0.75 KMT2A (0.41) ALDH1A1NPC1RAB9AAKT1AKT2
SCHEMBL16151890 0.75 KMT2A (0.41) ALDH1A1NPC1RAB9AAKT1AKT2
SCHEMBL685406 0.74 KDM4E (0.46) L3MBTL1ALDH1A1HPGDHTTMAPT
SCHEMBL2738591 0.74 AKT1 (0.46) L3MBTL1ALDH1A1HPGDHTTMAPT
SCHEMBL16151906 0.73 CACNA1B (0.39) L3MBTL1ALDH1A1HTTSMN1; SMN2POLB
SCHEMBL679637 0.73 AKT1 (0.45) L3MBTL1ALDH1A1HPGDHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853199-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA, INC. (US) 2014-10-07 US disclosed